Literature DB >> 26376866

Abnormalities of motor function, transcription and cerebellar structure in mouse models of THAP1 dystonia.

Marta Ruiz1, Georgina Perez-Garcia2, Maitane Ortiz-Virumbrales2, Aurelie Méneret3, Andrika Morant2, Jessica Kottwitz2, Tania Fuchs2, Justine Bonet2, Pedro Gonzalez-Alegre4, Patrick R Hof5, Laurie J Ozelius6, Michelle E Ehrlich7.   

Abstract

DYT6 dystonia is caused by mutations in THAP1 [Thanatos-associated (THAP) domain-containing apoptosis-associated protein] and is autosomal dominant and partially penetrant. Like other genetic primary dystonias, DYT6 patients have no characteristic neuropathology, and mechanisms by which mutations in THAP1 cause dystonia are unknown. Thap1 is a zinc-finger transcription factor, and most pathogenic THAP1 mutations are missense and are located in the DNA-binding domain. There are also nonsense mutations, which act as the equivalent of a null allele because they result in the generation of small mRNA species that are likely rapidly degraded via nonsense-mediated decay. The function of Thap1 in neurons is unknown, but there is a unique, neuronal 50-kDa Thap1 species, and Thap1 levels are auto-regulated on the mRNA level. Herein, we present the first characterization of two mouse models of DYT6, including a pathogenic knockin mutation, C54Y and a null mutation. Alterations in motor behaviors, transcription and brain structure are demonstrated. The projection neurons of the deep cerebellar nuclei are especially altered. Abnormalities vary according to genotype, sex, age and/or brain region, but importantly, overlap with those of other dystonia mouse models. These data highlight the similarities and differences in age- and cell-specific effects of a Thap1 mutation, indicating that the pathophysiology of THAP1 mutations should be assayed at multiple ages and neuronal types and support the notion of final common pathways in the pathophysiology of dystonia arising from disparate mutations.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26376866      PMCID: PMC4757965          DOI: 10.1093/hmg/ddv384

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  49 in total

Review 1.  Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism.

Authors:  Sheila M Fleming; Marie-Françoise Chesselet
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

2.  Development of the deep cerebellar nuclei: transcription factors and cell migration from the rhombic lip.

Authors:  Andrew J Fink; Chris Englund; Ray A M Daza; Diane Pham; Charmaine Lau; Mary Nivison; Tom Kowalczyk; Robert F Hevner
Journal:  J Neurosci       Date:  2006-03-15       Impact factor: 6.167

Review 3.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

Review 4.  The distribution and significance of CNS adrenoceptors examined with in situ hybridization.

Authors:  A P Nicholas; T Hökfelt; V A Pieribone
Journal:  Trends Pharmacol Sci       Date:  1996-07       Impact factor: 14.819

5.  β1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons.

Authors:  John Meitzen; Jessie I Luoma; Christopher M Stern; Paul G Mermelstein
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

6.  Molecular and physiological effects of alpha-tropomyosin ablation in the mouse.

Authors:  P Rethinasamy; M Muthuchamy; T Hewett; G Boivin; B M Wolska; C Evans; R J Solaro; D F Wieczorek
Journal:  Circ Res       Date:  1998 Jan 9-23       Impact factor: 17.367

7.  Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.

Authors:  Chang-Hyun Song; Xueliang Fan; Cicely J Exeter; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2012-05-31       Impact factor: 5.996

Review 8.  Neural cell cycle dysregulation and central nervous system diseases.

Authors:  Wei Wang; Bitao Bu; Minjie Xie; Min Zhang; Zhiyuan Yu; Deding Tao
Journal:  Prog Neurobiol       Date:  2009-02-04       Impact factor: 11.685

Review 9.  Genetic animal models of dystonia: common features and diversities.

Authors:  Franziska Richter; Angelika Richter
Journal:  Prog Neurobiol       Date:  2014-07-15       Impact factor: 11.685

10.  Altered dendritic morphology of Purkinje cells in Dyt1 ΔGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice.

Authors:  Lin Zhang; Fumiaki Yokoi; Yuan-Hu Jin; Mark P DeAndrade; Kenji Hashimoto; David G Standaert; Yuqing Li
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

View more
  20 in total

1.  Cerebellar Involvement in DYT-THAP1 Dystonia.

Authors:  Petyo Nikolov; Shady S Hassan; Aykut Aytulun; Christian J Hartmann; Jürgen Kohlhase; Alfons Schnitzler; Philipp Albrecht; Martina Minnerop; Stefan Jun Groiss
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

2.  Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia.

Authors:  Mark P DeAndrade; Amy Trongnetrpunya; Fumiaki Yokoi; Chad C Cheetham; Ning Peng; J Michael Wyss; Mingzhou Ding; Yuqing Li
Journal:  Mov Disord       Date:  2016-05-31       Impact factor: 10.338

3.  Motor phenotypes and molecular networks associated with germline deficiency of Ciz1.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Korah P Kuruvilla; Esther M Marquez-Lona; Madison R Cobb; Mark S LeDoux
Journal:  Exp Neurol       Date:  2016-05-07       Impact factor: 5.330

4.  The DYT6 Dystonia Protein THAP1 Regulates Myelination within the Oligodendrocyte Lineage.

Authors:  Dhananjay Yellajoshyula; Chun-Chi Liang; Samuel S Pappas; Silvia Penati; Angela Yang; Rodan Mecano; Ravindran Kumaran; Stephanie Jou; Mark R Cookson; William T Dauer
Journal:  Dev Cell       Date:  2017-07-10       Impact factor: 12.270

Review 5.  Emerging and converging molecular mechanisms in dystonia.

Authors:  Paulina Gonzalez-Latapi; Nicolas Marotta; Niccolò E Mencacci
Journal:  J Neural Transm (Vienna)       Date:  2021-01-01       Impact factor: 3.575

6.  Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.

Authors:  Karen L Eskow Jaunarajs; Mariangela Scarduzio; Michelle E Ehrlich; Lori L McMahon; David G Standaert
Journal:  J Neurosci       Date:  2019-07-18       Impact factor: 6.167

Review 7.  Defining research priorities in dystonia.

Authors:  Codrin Lungu; Laurie Ozelius; David Standaert; Mark Hallett; Beth-Anne Sieber; Christine Swanson-Fisher; Brian D Berman; Nicole Calakos; Jennifer C Moore; Joel S Perlmutter; Sarah E Pirio Richardson; Rachel Saunders-Pullman; Laura Scheinfeldt; Nutan Sharma; Roy Sillitoe; Kristina Simonyan; Philip A Starr; Anna Taylor; Jerrold Vitek
Journal:  Neurology       Date:  2020-02-25       Impact factor: 9.910

8.  Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes.

Authors:  Natalie M Frederick; Parth V Shah; Alessandro Didonna; Monica R Langley; Anumantha G Kanthasamy; Puneet Opal
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

9.  Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Francesca A Carlisle; Adrian J Waite; Derek J Blake; Ioannis Dragatsis; Yu Zhao; Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2016-11-24       Impact factor: 5.996

10.  Abnormal cerebellar function and tremor in a mouse model for non-manifesting partially penetrant dystonia type 6.

Authors:  Meike E van der Heijden; Dominic J Kizek; Ross Perez; Elena K Ruff; Michelle E Ehrlich; Roy V Sillitoe
Journal:  J Physiol       Date:  2021-01-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.